CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
ISPR
Ispire Technology Inc.
There isn't enough reported data to score ISPR yet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ISPR Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Unavailable |
ISPR's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
ISPR PE Valuation
ISPR has no meaningful PE right now: it lost money over the past year.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
ISPR Forward outlook
There aren't enough analyst estimates for ISPR to show an outlook.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over ISPR on earnings quality, reporting a profit while its opponent remains loss making.
ISPR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.63 | +$0.02 |
| Q2 2026 | -$0.58 | +$0.11 |
| Q1 2026 | -$0.61 | -$0.12 |
| Q4 2025 | -$0.63 | -$0.22 |
| Q3 2025 | -$0.65 | -$0.31 |
| Q2 2025 | -$0.69 | -$0.42 |
| Q1 2025 | -$0.49 | -$0.25 |
| Q4 2024 | -$0.41 | -$0.23 |
ISPR lost $0.63 per share over the past year, about the same as its loss the year before.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over ISPR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over ISPR on profitability, with a higher operating margin.
ISPR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $27.5M | -9.3% |
| Q2 2026 | $26.7M | +33% |
| Q1 2026 | $18.7M | -29% |
| Q4 2025 | $20.3M | -51% |
| Q3 2025 | $30.4M | -23% |
| Q2 2025 | $20.1M | -46% |
| Q1 2025 | $26.2M | -13% |
| Q4 2024 | $41.8M | +0.3% |
ISPR's revenue has slid since its 2023 peak: $28M last quarter, down 9.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -22% | -13 points |
| Q2 2026 | -51% | +22 points |
| Q1 2026 | -51% | -10 points |
| Q4 2025 | -34% | -16 points |
| Q3 2025 | -8.9% | +4.5 points |
| Q2 2025 | -73% | -64 points |
| Q1 2025 | -40% | -22 points |
| Q4 2024 | -18% | -8.1 points |
ISPR's operating margin was −22% last quarter, down 13 points from the same quarter a year ago.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over ISPR on cash generation, producing positive trailing cash flow while its opponent burns cash.
ISPR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6M | -$429.4K |
| Q2 2026 | $2.6M | -29% |
| Q1 2026 | $1.7M | +$14M |
| Q4 2025 | -$4M | -$800.1K |
| Q3 2025 | -$1.2M | -136% |
| Q2 2025 | $3.7M | +$5.9M |
| Q1 2025 | -$12.3M | -476% |
| Q4 2024 | -$3.2M | +$4.7M |
ISPR has burned cash in most quarters: −$1M over the past year, against −$13M the year before.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over ISPR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
ISPR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +364K shares |
| 1 year | +0.7% | +398K shares |
| 3 years | +6.3% | +3.4M shares |
| 5 years | +15% | +7.7M shares |
ISPR has 58M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q2 2025 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
ISPR Net Leverage
ISPR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
ISPR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.6 | Neutral |
| Stochastic | 54.5 | Neutral |
ISPR's weekly RSI is 54 (neutral) and its Stochastic is 55 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
ISPR PE vs Consumer Defensive Sector
ISPR has no meaningful PE right now: it lost money over the past year.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
ISPR has stronger trend alignment. CELH is above 2 of 5 weekly averages versus ISPR above 2 of 4.
ISPR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.45 | 20% above |
| 20 week MA | $1.49 | 17% above |
| 50 week MA | $1.92 | 9.4% below |
| 100 week MA | $2.55 | 32% below |
ISPR has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 32% below its 100-week average.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over ISPR on returns for 2026, with the stronger performance.
ISPR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $7.08 | $12.1 | +71% |
| 2024 | $12.1 | $5.26 | -57% |
| 2025 | $5.26 | $2.85 | -46% |
| 2026 YTD | $2.85 | $1.74 | -39% |
ISPR has finished lower in two of the last three years. It's down 39% so far in 2026.